Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Whitehead

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|June 16, 1990
Oestrogens, arterial status, and postmenopausal womenT Bourne, T C Hillard, M I Whitehead, et al.
BMJ (Clinical Research Ed.)|December 2, 1989
Transabdominal ultrasound screening for early ovarian cancerS Campbell, V Bhan, P Royston, et al.
BMJ (Clinical Research Ed.)|December 2, 1989
Transvaginal colour flow imaging: a possible new screening technique for ovarian cancerT Bourne, S Campbell, C Steer, et al.
BMJ (Clinical Research Ed.)|September 19, 1992
Oestrogen replacement after oophorectomyJ C Stevenson, T C Hillard, S I Whitcroft, et al.
Maturitas|December 10, 1997
Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometriumD Ross, V Godfree, A Cooper, et al.
Lancet (London, England)|February 10, 1990
Transdermal administration of oestrogen/progestagen hormone replacement therapyM I Whitehead, D Fraser, L Schenkel, et al.
Drug Safety|September 1, 1990
A risk-benefit assessment of estrogen therapy in postmenopausal womenM P Cust, K F Gangar, T C Hillard, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1989
Progesterone in saliva as an index of ovarian functionA O Adekunle, J B Kim, W P Collins, et al.
International Journal of Fertility and Menopausal Studies|January 1, 1993
Oral versus transdermal hormone replacement therapyJ C Stevenson, D Crook, I F Godsland, et al.
Drugs|January 1, 1994
Hormone replacement therapy and the cardiovascular system. Nonlipid effectsJ C Stevenson, D Crook, I F Godsland, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|June 16, 1990
Oestrogens, arterial status, and postmenopausal womenT Bourne, T C Hillard, M I Whitehead, et al.
BMJ (Clinical Research Ed.)|December 2, 1989
Transabdominal ultrasound screening for early ovarian cancerS Campbell, V Bhan, P Royston, et al.
BMJ (Clinical Research Ed.)|December 2, 1989
Transvaginal colour flow imaging: a possible new screening technique for ovarian cancerT Bourne, S Campbell, C Steer, et al.
BMJ (Clinical Research Ed.)|September 19, 1992
Oestrogen replacement after oophorectomyJ C Stevenson, T C Hillard, S I Whitcroft, et al.
Maturitas|December 10, 1997
Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometriumD Ross, V Godfree, A Cooper, et al.
Lancet (London, England)|February 10, 1990
Transdermal administration of oestrogen/progestagen hormone replacement therapyM I Whitehead, D Fraser, L Schenkel, et al.
Drug Safety|September 1, 1990
A risk-benefit assessment of estrogen therapy in postmenopausal womenM P Cust, K F Gangar, T C Hillard, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1989
Progesterone in saliva as an index of ovarian functionA O Adekunle, J B Kim, W P Collins, et al.
International Journal of Fertility and Menopausal Studies|January 1, 1993
Oral versus transdermal hormone replacement therapyJ C Stevenson, D Crook, I F Godsland, et al.
Drugs|January 1, 1994
Hormone replacement therapy and the cardiovascular system. Nonlipid effectsJ C Stevenson, D Crook, I F Godsland, et al.
Pageof 14